Medical Exoskeleton Market By Type, By Mobility, By Component, By Application: Global Opportunity Analysis and Industry Forecast, 2021-2031

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. High bargaining power of suppliers
3.3.2. Moderate bargaining power of buyers
3.3.3. High threat of substitutes
3.3.4. High threat of new entrants
3.3.5. High intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in the prevalence of neurological disorders.
3.4.1.2. Increase in the number of spinal cord injuries and brain injuries.
3.4.1.3. Rise in the number of geriatric populations.
3.4.2. Restraints
3.4.2.1. Regulatory challenges for securing approvals for medical applications of exoskeletons.
3.4.3. Opportunities
3.4.3.1. Increase in the number of product approvals by market players.
3.4.3.2. Rise in the number of adoptions of key Strategies by market players
3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: MEDICAL EXOSKELETON MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Powered exoskeleton
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Passive exoskeleton
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country

CHAPTER 5: MEDICAL EXOSKELETON MARKET, BY MOBILITY
5.1. Overview
5.1.1. Market size and forecast
5.2. Stationary
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Mobile
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country

CHAPTER 6: MEDICAL EXOSKELETON MARKET, BY COMPONENT
6.1. Overview
6.1.1. Market size and forecast
6.2. Hardware
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Software
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country

CHAPTER 7: MEDICAL EXOSKELETON MARKET, BY APPLICATION
7.1. Overview
7.1.1. Market size and forecast
7.2. Spinal Cord Injury
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis by country
7.3. Stroke
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis by country
7.4. Others
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by region
7.4.3. Market share analysis by country

CHAPTER 8: MEDICAL EXOSKELETON MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast By Region
8.2. North America
8.2.1. Key trends and opportunities
8.2.2. Market size and forecast, by Type
8.2.3. Market size and forecast, by Mobility
8.2.4. Market size and forecast, by Component
8.2.5. Market size and forecast, by Application
8.2.6. Market size and forecast, by country
8.2.6.1. U.S.
8.2.6.1.1. Key market trends, growth factors and opportunities
8.2.6.1.2. Market size and forecast, by Type
8.2.6.1.3. Market size and forecast, by Mobility
8.2.6.1.4. Market size and forecast, by Component
8.2.6.1.5. Market size and forecast, by Application
8.2.6.2. Canada
8.2.6.2.1. Key market trends, growth factors and opportunities
8.2.6.2.2. Market size and forecast, by Type
8.2.6.2.3. Market size and forecast, by Mobility
8.2.6.2.4. Market size and forecast, by Component
8.2.6.2.5. Market size and forecast, by Application
8.2.6.3. Mexico
8.2.6.3.1. Key market trends, growth factors and opportunities
8.2.6.3.2. Market size and forecast, by Type
8.2.6.3.3. Market size and forecast, by Mobility
8.2.6.3.4. Market size and forecast, by Component
8.2.6.3.5. Market size and forecast, by Application
8.3. Europe
8.3.1. Key trends and opportunities
8.3.2. Market size and forecast, by Type
8.3.3. Market size and forecast, by Mobility
8.3.4. Market size and forecast, by Component
8.3.5. Market size and forecast, by Application
8.3.6. Market size and forecast, by country
8.3.6.1. Germany
8.3.6.1.1. Key market trends, growth factors and opportunities
8.3.6.1.2. Market size and forecast, by Type
8.3.6.1.3. Market size and forecast, by Mobility
8.3.6.1.4. Market size and forecast, by Component
8.3.6.1.5. Market size and forecast, by Application
8.3.6.2. France
8.3.6.2.1. Key market trends, growth factors and opportunities
8.3.6.2.2. Market size and forecast, by Type
8.3.6.2.3. Market size and forecast, by Mobility
8.3.6.2.4. Market size and forecast, by Component
8.3.6.2.5. Market size and forecast, by Application
8.3.6.3. UK
8.3.6.3.1. Key market trends, growth factors and opportunities
8.3.6.3.2. Market size and forecast, by Type
8.3.6.3.3. Market size and forecast, by Mobility
8.3.6.3.4. Market size and forecast, by Component
8.3.6.3.5. Market size and forecast, by Application
8.3.6.4. Italy
8.3.6.4.1. Key market trends, growth factors and opportunities
8.3.6.4.2. Market size and forecast, by Type
8.3.6.4.3. Market size and forecast, by Mobility
8.3.6.4.4. Market size and forecast, by Component
8.3.6.4.5. Market size and forecast, by Application
8.3.6.5. Spain
8.3.6.5.1. Key market trends, growth factors and opportunities
8.3.6.5.2. Market size and forecast, by Type
8.3.6.5.3. Market size and forecast, by Mobility
8.3.6.5.4. Market size and forecast, by Component
8.3.6.5.5. Market size and forecast, by Application
8.3.6.6. Rest of Europe
8.3.6.6.1. Key market trends, growth factors and opportunities
8.3.6.6.2. Market size and forecast, by Type
8.3.6.6.3. Market size and forecast, by Mobility
8.3.6.6.4. Market size and forecast, by Component
8.3.6.6.5. Market size and forecast, by Application
8.4. Asia-Pacific
8.4.1. Key trends and opportunities
8.4.2. Market size and forecast, by Type
8.4.3. Market size and forecast, by Mobility
8.4.4. Market size and forecast, by Component
8.4.5. Market size and forecast, by Application
8.4.6. Market size and forecast, by country
8.4.6.1. Japan
8.4.6.1.1. Key market trends, growth factors and opportunities
8.4.6.1.2. Market size and forecast, by Type
8.4.6.1.3. Market size and forecast, by Mobility
8.4.6.1.4. Market size and forecast, by Component
8.4.6.1.5. Market size and forecast, by Application
8.4.6.2. China
8.4.6.2.1. Key market trends, growth factors and opportunities
8.4.6.2.2. Market size and forecast, by Type
8.4.6.2.3. Market size and forecast, by Mobility
8.4.6.2.4. Market size and forecast, by Component
8.4.6.2.5. Market size and forecast, by Application
8.4.6.3. India
8.4.6.3.1. Key market trends, growth factors and opportunities
8.4.6.3.2. Market size and forecast, by Type
8.4.6.3.3. Market size and forecast, by Mobility
8.4.6.3.4. Market size and forecast, by Component
8.4.6.3.5. Market size and forecast, by Application
8.4.6.4. Australia
8.4.6.4.1. Key market trends, growth factors and opportunities
8.4.6.4.2. Market size and forecast, by Type
8.4.6.4.3. Market size and forecast, by Mobility
8.4.6.4.4. Market size and forecast, by Component
8.4.6.4.5. Market size and forecast, by Application
8.4.6.5. South Korea
8.4.6.5.1. Key market trends, growth factors and opportunities
8.4.6.5.2. Market size and forecast, by Type
8.4.6.5.3. Market size and forecast, by Mobility
8.4.6.5.4. Market size and forecast, by Component
8.4.6.5.5. Market size and forecast, by Application
8.4.6.6. Rest of Asia-Pacific
8.4.6.6.1. Key market trends, growth factors and opportunities
8.4.6.6.2. Market size and forecast, by Type
8.4.6.6.3. Market size and forecast, by Mobility
8.4.6.6.4. Market size and forecast, by Component
8.4.6.6.5. Market size and forecast, by Application
8.5. LAMEA
8.5.1. Key trends and opportunities
8.5.2. Market size and forecast, by Type
8.5.3. Market size and forecast, by Mobility
8.5.4. Market size and forecast, by Component
8.5.5. Market size and forecast, by Application
8.5.6. Market size and forecast, by country
8.5.6.1. Brazil
8.5.6.1.1. Key market trends, growth factors and opportunities
8.5.6.1.2. Market size and forecast, by Type
8.5.6.1.3. Market size and forecast, by Mobility
8.5.6.1.4. Market size and forecast, by Component
8.5.6.1.5. Market size and forecast, by Application
8.5.6.2. Saudi Arabia
8.5.6.2.1. Key market trends, growth factors and opportunities
8.5.6.2.2. Market size and forecast, by Type
8.5.6.2.3. Market size and forecast, by Mobility
8.5.6.2.4. Market size and forecast, by Component
8.5.6.2.5. Market size and forecast, by Application
8.5.6.3. South Africa
8.5.6.3.1. Key market trends, growth factors and opportunities
8.5.6.3.2. Market size and forecast, by Type
8.5.6.3.3. Market size and forecast, by Mobility
8.5.6.3.4. Market size and forecast, by Component
8.5.6.3.5. Market size and forecast, by Application
8.5.6.4. Rest of LAMEA
8.5.6.4.1. Key market trends, growth factors and opportunities
8.5.6.4.2. Market size and forecast, by Type
8.5.6.4.3. Market size and forecast, by Mobility
8.5.6.4.4. Market size and forecast, by Component
8.5.6.4.5. Market size and forecast, by Application

CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top winning Strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Top player positioning, 2021

CHAPTER 10: COMPANY PROFILES
10.1. CYBERDYNE INC.
10.1.1. Company overview
10.1.2. Key Executives
10.1.3. Company snapshot
10.1.4. Operating business segments
10.1.5. Product portfolio
10.1.6. Business performance
10.1.7. Key strategic moves and developments
10.2. Ekso Bionics
10.2.1. Company overview
10.2.2. Key Executives
10.2.3. Company snapshot
10.2.4. Operating business segments
10.2.5. Product portfolio
10.2.6. Business performance
10.2.7. Key strategic moves and developments
10.3. Ergosante
10.3.1. Company overview
10.3.2. Key Executives
10.3.3. Company snapshot
10.3.4. Operating business segments
10.3.5. Product portfolio
10.4. B-Temia
10.4.1. Company overview
10.4.2. Key Executives
10.4.3. Company snapshot
10.4.4. Operating business segments
10.4.5. Product portfolio
10.4.6. Key strategic moves and developments
10.5. ExoAtlet
10.5.1. Company overview
10.5.2. Key Executives
10.5.3. Company snapshot
10.5.4. Operating business segments
10.5.5. Product portfolio
10.6. Rewalk Robotics
10.6.1. Company overview
10.6.2. Key Executives
10.6.3. Company snapshot
10.6.4. Operating business segments
10.6.5. Product portfolio
10.6.6. Business performance
10.6.7. Key strategic moves and developments
10.7. Ottobock SE & Co. KGaA (suit X)
10.7.1. Company overview
10.7.2. Key Executives
10.7.3. Company snapshot
10.7.4. Operating business segments
10.7.5. Product portfolio
10.8. Human Motion Technologies LLC
10.8.1. Company overview
10.8.2. Key Executives
10.8.3. Company snapshot
10.8.4. Operating business segments
10.8.5. Product portfolio
10.9. Wearable Robotics srl
10.9.1. Company overview
10.9.2. Key Executives
10.9.3. Company snapshot
10.9.4. Operating business segments
10.9.5. Product portfolio
10.10. DIH Medical
10.10.1. Company overview
10.10.2. Key Executives
10.10.3. Company snapshot
10.10.4. Operating business segments
10.10.5. Product portfolio

List of Tables
Table 01. Global Medical Exoskeleton Market, by Type, 2021-2031 (Revenue, $Million)
Table 02. Medical Exoskeleton Market for Powered Exoskeleton, by Region, 2021-2031 (Revenue, $Million)
Table 03. Medical Exoskeleton Market for Passive Exoskeleton, by Region, 2021-2031 (Revenue, $Million)
Table 04. Global Medical Exoskeleton Market, by Mobility, 2021-2031 (Revenue, $Million)
Table 05. Medical Exoskeleton Market for Stationary, by Region, 2021-2031 (Revenue, $Million)
Table 06. Medical Exoskeleton Market for Mobile, by Region, 2021-2031 (Revenue, $Million)
Table 07. Global Medical Exoskeleton Market, by Component, 2021-2031 (Revenue, $Million)
Table 08. Medical Exoskeleton Market for Hardware, by Region, 2021-2031 (Revenue, $Million)
Table 09. Medical Exoskeleton Market for Software, by Region, 2021-2031 (Revenue, $Million)
Table 10. Global Medical Exoskeleton Market, by Application, 2021-2031 (Revenue, $Million)
Table 11. Medical Exoskeleton Market for Spinal Cord Injury, by Region, 2021-2031 (Revenue, $Million)
Table 12. Medical Exoskeleton Market for Stroke, by Region, 2021-2031 (Revenue, $Million)
Table 13. Medical Exoskeleton Market for Others, by Region, 2021-2031 (Revenue, $Million)
Table 14. Medical Exoskeleton Market, by Region, 2021-2031 (Revenue, $Million)
Table 15. North America Medical Exoskeleton Market, by Type, 2021-2031 (Revenue, $Million)
Table 16. North America Medical Exoskeleton Market, by Mobility, 2021-2031 (Revenue, $Million)
Table 17. North America Medical Exoskeleton Market, by Component, 2021-2031 (Revenue, $Million)
Table 18. North America Medical Exoskeleton Market, by Application, 2021-2031 (Revenue, $Million)
Table 19. North America Medical Exoskeleton Market, by Country, 2021-2031 (Revenue, $Million)
Table 20. U.S. Medical Exoskeleton Market, by Type, 2021-2031 (Revenue, $Million)
Table 21. U.S. Medical Exoskeleton Market, by Mobility, 2021-2031 (Revenue, $Million)
Table 22. U.S. Medical Exoskeleton Market, by Component, 2021-2031 (Revenue, $Million)
Table 23. U.S. Medical Exoskeleton Market, by Application, 2021-2031 (Revenue, $Million)
Table 24. Canada Medical Exoskeleton Market, by Type, 2021-2031 (Revenue, $Million)
Table 25. Canada Medical Exoskeleton Market, by Mobility, 2021-2031 (Revenue, $Million)
Table 26. Canada Medical Exoskeleton Market, by Component, 2021-2031 (Revenue, $Million)
Table 27. Canada Medical Exoskeleton Market, by Application, 2021-2031 (Revenue, $Million)
Table 28. Mexico Medical Exoskeleton Market, by Type, 2021-2031 (Revenue, $Million)
Table 29. Mexico Medical Exoskeleton Market, by Mobility, 2021-2031 (Revenue, $Million)
Table 30. Mexico Medical Exoskeleton Market, by Component, 2021-2031 (Revenue, $Million)
Table 31. Mexico Medical Exoskeleton Market, by Application, 2021-2031 (Revenue, $Million)
Table 32. Europe Medical Exoskeleton Market, by Type, 2021-2031 (Revenue, $Million)
Table 33. Europe Medical Exoskeleton Market, by Mobility, 2021-2031 (Revenue, $Million)
Table 34. Europe Medical Exoskeleton Market, by Component, 2021-2031 (Revenue, $Million)
Table 35. Europe Medical Exoskeleton Market, by Application, 2021-2031 (Revenue, $Million)
Table 36. Europe Medical Exoskeleton Market, by Country, 2021-2031 (Revenue, $Million)
Table 37. Germany Medical Exoskeleton Market, by Type, 2021-2031 (Revenue, $Million)
Table 38. Germany Medical Exoskeleton Market, by Mobility, 2021-2031 (Revenue, $Million)
Table 39. Germany Medical Exoskeleton Market, by Component, 2021-2031 (Revenue, $Million)
Table 40. Germany Medical Exoskeleton Market, by Application, 2021-2031 (Revenue, $Million)
Table 41. France Medical Exoskeleton Market, by Type, 2021-2031 (Revenue, $Million)
Table 42. France Medical Exoskeleton Market, by Mobility, 2021-2031 (Revenue, $Million)
Table 43. France Medical Exoskeleton Market, by Component, 2021-2031 (Revenue, $Million)
Table 44. France Medical Exoskeleton Market, by Application, 2021-2031 (Revenue, $Million)
Table 45. UK Medical Exoskeleton Market, by Type, 2021-2031 (Revenue, $Million)
Table 46. UK Medical Exoskeleton Market, by Mobility, 2021-2031 (Revenue, $Million)
Table 47. UK Medical Exoskeleton Market, by Component, 2021-2031 (Revenue, $Million)
Table 48. UK Medical Exoskeleton Market, by Application, 2021-2031 (Revenue, $Million)
Table 49. Italy Medical Exoskeleton Market, by Type, 2021-2031 (Revenue, $Million)
Table 50. Italy Medical Exoskeleton Market, by Mobility, 2021-2031 (Revenue, $Million)
Table 51. Italy Medical Exoskeleton Market, by Component, 2021-2031 (Revenue, $Million)
Table 52. Italy Medical Exoskeleton Market, by Application, 2021-2031 (Revenue, $Million)
Table 53. Spain Medical Exoskeleton Market, by Type, 2021-2031 (Revenue, $Million)
Table 54. Spain Medical Exoskeleton Market, by Mobility, 2021-2031 (Revenue, $Million)
Table 55. Spain Medical Exoskeleton Market, by Component, 2021-2031 (Revenue, $Million)
Table 56. Spain Medical Exoskeleton Market, by Application, 2021-2031 (Revenue, $Million)
Table 57. Rest of Europe Medical Exoskeleton Market, by Type, 2021-2031 (Revenue, $Million)
Table 58. Rest of Europe Medical Exoskeleton Market, by Mobility, 2021-2031 (Revenue, $Million)
Table 59. Rest of Europe Medical Exoskeleton Market, by Component, 2021-2031 (Revenue, $Million)
Table 60. Rest of Europe Medical Exoskeleton Market, by Application, 2021-2031 (Revenue, $Million)
Table 61. Asia-Pacific Medical Exoskeleton Market, by Type, 2021-2031 (Revenue, $Million)
Table 62. Asia-Pacific Medical Exoskeleton Market, by Mobility, 2021-2031 (Revenue, $Million)
Table 63. Asia-Pacific Medical Exoskeleton Market, by Component, 2021-2031 (Revenue, $Million)
Table 64. Asia-Pacific Medical Exoskeleton Market, by Application, 2021-2031 (Revenue, $Million)
Table 65. Asia-Pacific Medical Exoskeleton Market, by Country, 2021-2031 (Revenue, $Million)
Table 66. Japan Medical Exoskeleton Market, by Type, 2021-2031 (Revenue, $Million)
Table 67. Japan Medical Exoskeleton Market, by Mobility, 2021-2031 (Revenue, $Million)
Table 68. Japan Medical Exoskeleton Market, by Component, 2021-2031 (Revenue, $Million)
Table 69. Japan Medical Exoskeleton Market, by Application, 2021-2031 (Revenue, $Million)
Table 70. China Medical Exoskeleton Market, by Type, 2021-2031 (Revenue, $Million)
Table 71. China Medical Exoskeleton Market, by Mobility, 2021-2031 (Revenue, $Million)
Table 72. China Medical Exoskeleton Market, by Component, 2021-2031 (Revenue, $Million)
Table 73. China Medical Exoskeleton Market, by Application, 2021-2031 (Revenue, $Million)
Table 74. India Medical Exoskeleton Market, by Type, 2021-2031 (Revenue, $Million)
Table 75. India Medical Exoskeleton Market, by Mobility, 2021-2031 (Revenue, $Million)
Table 76. India Medical Exoskeleton Market, by Component, 2021-2031 (Revenue, $Million)
Table 77. India Medical Exoskeleton Market, by Application, 2021-2031 (Revenue, $Million)
Table 78. Australia Medical Exoskeleton Market, by Type, 2021-2031 (Revenue, $Million)
Table 79. Australia Medical Exoskeleton Market, by Mobility, 2021-2031 (Revenue, $Million)
Table 80. Australia Medical Exoskeleton Market, by Component, 2021-2031 (Revenue, $Million)
Table 81. Australia Medical Exoskeleton Market, by Application, 2021-2031 (Revenue, $Million)
Table 82. South Korea Medical Exoskeleton Market, by Type, 2021-2031 (Revenue, $Million)
Table 83. South Korea Medical Exoskeleton Market, by Mobility, 2021-2031 (Revenue, $Million)
Table 84. South Korea Medical Exoskeleton Market, by Component, 2021-2031 (Revenue, $Million)
Table 85. South Korea Medical Exoskeleton Market, by Application, 2021-2031 (Revenue, $Million)
Table 86. Rest of Asia-Pacific Medical Exoskeleton Market, by Type, 2021-2031 (Revenue, $Million)
Table 87. Rest of Asia-Pacific Medical Exoskeleton Market, by Mobility, 2021-2031 (Revenue, $Million)
Table 88. Rest of Asia-Pacific Medical Exoskeleton Market, by Component, 2021-2031 (Revenue, $Million)
Table 89. Rest of Asia-Pacific Medical Exoskeleton Market, by Application, 2021-2031 (Revenue, $Million)
Table 90. LAMEA Medical Exoskeleton Market, by Type, 2021-2031 (Revenue, $Million)
Table 91. LAMEA Medical Exoskeleton Market, by Mobility, 2021-2031 (Revenue, $Million)
Table 92. LAMEA Medical Exoskeleton Market, by Component, 2021-2031 (Revenue, $Million)
Table 93. LAMEA Medical Exoskeleton Market, by Application, 2021-2031 (Revenue, $Million)
Table 94. LAMEA Medical Exoskeleton Market, by Country, 2021-2031 (Revenue, $Million)
Table 95. Brazil Medical Exoskeleton Market, by Type, 2021-2031 (Revenue, $Million)
Table 96. Brazil Medical Exoskeleton Market, by Mobility, 2021-2031 (Revenue, $Million)
Table 97. Brazil Medical Exoskeleton Market, by Component, 2021-2031 (Revenue, $Million)
Table 98. Brazil Medical Exoskeleton Market, by Application, 2021-2031 (Revenue, $Million)
Table 99. Saudi Arabia Medical Exoskeleton Market, by Type, 2021-2031 (Revenue, $Million)
Table 100. Saudi Arabia Medical Exoskeleton Market, by Mobility, 2021-2031 (Revenue, $Million)
Table 101. Saudi Arabia Medical Exoskeleton Market, by Component, 2021-2031 (Revenue, $Million)
Table 102. Saudi Arabia Medical Exoskeleton Market, by Application, 2021-2031 (Revenue, $Million)
Table 103. South Africa Medical Exoskeleton Market, by Type, 2021-2031 (Revenue, $Million)
Table 104. South Africa Medical Exoskeleton Market, by Mobility, 2021-2031 (Revenue, $Million)
Table 105. South Africa Medical Exoskeleton Market, by Component, 2021-2031 (Revenue, $Million)
Table 106. South Africa Medical Exoskeleton Market, by Application, 2021-2031 (Revenue, $Million)
Table 107. Rest of LAMEA Medical Exoskeleton Market, by Type, 2021-2031 (Revenue, $Million)
Table 108. Rest of LAMEA Medical Exoskeleton Market, by Mobility, 2021-2031 (Revenue, $Million)
Table 109. Rest of LAMEA Medical Exoskeleton Market, by Component, 2021-2031 (Revenue, $Million)
Table 110. Rest of LAMEA Medical Exoskeleton Market, by Application, 2021-2031 (Revenue, $Million)
Table 111. Cyberdyne Inc.: Key Executives
Table 112. Cyberdyne Inc.: Company Snapshot
Table 113. Cyberdyne Inc.: Product Segments
Table 114. Cyberdyne Inc.: Product Portfolio
Table 115. Cyberdyne Inc.: Key Strategies
Table 116. Ekso Bionics: Key Executives
Table 117. Ekso Bionics: Company Snapshot
Table 118. Ekso Bionics: Product Segments
Table 119. Ekso Bionics: Product Portfolio
Table 120. Ekso Bionics: Key Strategies
Table 121. Ergosante: Key Executives
Table 122. Ergosante: Company Snapshot
Table 123. Ergosante: Product Segments
Table 124. Ergosante: Product Portfolio
Table 125. B-Temia: Key Executives
Table 126. B-Temia: Company Snapshot
Table 127. B-Temia: Product Segments
Table 128. B-Temia: Product Portfolio
Table 129. B-Temia: Key Strategies
Table 130. Exoatlet: Key Executives
Table 131. Exoatlet: Company Snapshot
Table 132. Exoatlet: Product Segments
Table 133. Exoatlet: Product Portfolio
Table 134. Rewalk Robotics: Key Executives
Table 135. Rewalk Robotics: Company Snapshot
Table 136. Rewalk Robotics: Product Segments
Table 137. Rewalk Robotics: Product Portfolio
Table 138. Rewalk Robotics: Key Strategies
Table 139. Ottobock SE & Co. KGaA (Suit X): Key Executives
Table 140. Ottobock SE & Co. KGaA (Suit X): Company Snapshot
Table 141. Ottobock SE & Co. KGaA (Suit X): Product Segments
Table 142. Ottobock SE & Co. KGaA (Suit X): Product Portfolio
Table 143. Human Motion Technologies LLC: Key Executives
Table 144. Human Motion Technologies LLC: Company Snapshot
Table 145. Human Motion Technologies LLC: Product Segments
Table 146. Human Motion Technologies LLC: Product Portfolio
Table 147. Wearable Robotics Srl: Key Executives
Table 148. Wearable Robotics Srl: Company Snapshot
Table 149. Wearable Robotics Srl: Product Segments
Table 150. Wearable Robotics Srl: Product Portfolio
Table 151. Dih Medical: Key Executives
Table 152. Dih Medical: Company Snapshot
Table 153. Dih Medical: Product Segments
Table 154. Dih Medical: Product Portfolio

List of Figures
Figure 01. Medical Exoskeleton Market, 2021-2031
Figure 02. Segmentation of Medical Exoskeleton Market, 2021-2031
Figure 03. Top Investment Pockets in Medical Exoskeleton Market (2022-2031)
Figure 04. High Bargaining Power of Suppliers
Figure 05. Moderate Bargaining Power of Buyers
Figure 06. High Threat of Substitutes
Figure 07. High Threat of New Entrants
Figure 08. High Intensity of Rivalry
Figure 09. Drivers, Restraints and Opportunities: Globalmedical Exoskeleton Market
Figure 10. Medical Exoskeleton Market, by Type, 2021(%)
Figure 11. Comparative Share Analysis of Medical Exoskeleton Market for Powered Exoskeleton, by Country 2021-2031(%)
Figure 12. Comparative Share Analysis of Medical Exoskeleton Market for Passive Exoskeleton, by Country 2021-2031(%)
Figure 13. Medical Exoskeleton Market, by Mobility, 2021(%)
Figure 14. Comparative Share Analysis of Medical Exoskeleton Market for Stationary, by Country 2021-2031(%)
Figure 15. Comparative Share Analysis of Medical Exoskeleton Market for Mobile, by Country 2021-2031(%)
Figure 16. Medical Exoskeleton Market, by Component, 2021(%)
Figure 17. Comparative Share Analysis of Medical Exoskeleton Market for Hardware, by Country 2021-2031(%)
Figure 18. Comparative Share Analysis of Medical Exoskeleton Market for Software, by Country 2021-2031(%)
Figure 19. Medical Exoskeleton Market, by Application, 2021(%)
Figure 20. Comparative Share Analysis of Medical Exoskeleton Market for Spinal Cord Injury, by Country 2021-2031(%)
Figure 21. Comparative Share Analysis of Medical Exoskeleton Market for Stroke, by Country 2021-2031(%)
Figure 22. Comparative Share Analysis of Medical Exoskeleton Market for Others, by Country 2021-2031(%)
Figure 23. Medical Exoskeleton Market by Region, 2021
Figure 24. U.S. Medical Exoskeleton Market, 2021-2031 ($Million)
Figure 25. Canada Medical Exoskeleton Market, 2021-2031 ($Million)
Figure 26. Mexico Medical Exoskeleton Market, 2021-2031 ($Million)
Figure 27. Germany Medical Exoskeleton Market, 2021-2031 ($Million)
Figure 28. France Medical Exoskeleton Market, 2021-2031 ($Million)
Figure 29. UK Medical Exoskeleton Market, 2021-2031 ($Million)
Figure 30. Italy Medical Exoskeleton Market, 2021-2031 ($Million)
Figure 31. Spain Medical Exoskeleton Market, 2021-2031 ($Million)
Figure 32. Rest of Europe Medical Exoskeleton Market, 2021-2031 ($Million)
Figure 33. Japan Medical Exoskeleton Market, 2021-2031 ($Million)
Figure 34. China Medical Exoskeleton Market, 2021-2031 ($Million)
Figure 35. India Medical Exoskeleton Market, 2021-2031 ($Million)
Figure 36. Australia Medical Exoskeleton Market, 2021-2031 ($Million)
Figure 37. South Korea Medical Exoskeleton Market, 2021-2031 ($Million)
Figure 38. Rest of Asia-Pacific Medical Exoskeleton Market, 2021-2031 ($Million)
Figure 39. Brazil Medical Exoskeleton Market, 2021-2031 ($Million)
Figure 40. Saudi Arabia Medical Exoskeleton Market, 2021-2031 ($Million)
Figure 41. South Africa Medical Exoskeleton Market, 2021-2031 ($Million)
Figure 42. Rest of LAMEA Medical Exoskeleton Market, 2021-2031 ($Million)
Figure 43. Top Winning Strategies, by Year
Figure 44. Top Winning Strategies, by Development
Figure 45. Top Winning Strategies, by Company
Figure 46. Product Mapping of Top 10 Players
Figure 47. Competitive Dashboard
Figure 48. Competitive Heatmap: Medical Exoskeleton Market
Figure 49. Top Player Positioning, 2021
Figure 50. Cyberdyne Inc.: Net Revenue, 2019-2021 ($Million)
Figure 51. Cyberdyne Inc.: Research & Development Expenditure, 2019-2021
Figure 52. Ekso Bionics: Net Revenue, 2019-2021 ($Million)
Figure 53. Ekso Bionics: Research & Development Expenditure, 2019-2021
Figure 54. Ekso Bionics: Revenue Share by Segment, 2021 (%)
Figure 55. Ekso Bionics: Revenue Share by Region, 2021 (%)
Figure 56. Rewalk Robotics: Net Revenue, 2019-2021 ($Million)
Figure 57. Rewalk Robotics: Research & Development Expenditure, 2019-2021
Figure 58. Rewalk Robotics: Revenue Share by Region, 2021 (%)

Executive Summary

According to the report titled, 'Medical Exoskeleton Market,' the medical exoskeleton market was valued at $232.49 million in 2021, and is estimated to reach $3,044.7 million by 2031, growing at a CAGR of 29.4% from 2022 to 2031. Medical exoskeletons are used to enhance the physical strength of the human by assisting the limb movement with extra strength. There are two types of medical exoskeletons devices powered exoskeleton and passive exoskeleton. The component of medical exoskeleton devices includes hardware and software. Based on mobility the there are two types of medical exoskeleton devices which includes stationary and mobile. The application of medical exoskeleton devices includes spinal cord injury, stroke, and others. Others include multiple sclerosis, osteoarthritis, Parkinson’s disease and acquired brain injuries.

Key factors driving the growth of the medical exoskeleton market include increase in the prevalence of neurological disorders, increase in the number of spinal cord injuries and brain injuries. rise in the number of geriatric populations. Geriatric population is majorly susceptible to suffer from neurological diseases, orthopedic disease such as arthritis and fall injuries. Thus, rise in number of geriatric populations is anticipated to drive the demand for medical exoskeleton devices and is anticipated to drive the growth of the market. For instance, according to the U.S. Census Bureau data published in December 2021, more than 56 million adults ages 65 i.e., 16.9% of the nation’s population and by 2050, is estimated to rise 85.7 million. In addition, according to Centers for Disease Control, (CDC), it was reported that, by 2040, an estimated 78 million (26%) US adults are projected to have doctor-diagnosed arthritis. Moreover, in 2020, according to the Journal of eClinicalMedicine around 654⋅1 million individuals (40 years and older) were diagnosed with knee osteoarthritis, across the globe
The market also offers growth opportunities to the key players in the market. Moreover, rise in number of product launches and product approvals for medical exoskeleton devices are anticipated to boost the market growth. For instance, in June 2020, Ekso Bionics Holdings, Inc., an industry leader in exoskeleton technology for medical and industrial use, announced it has received 501(k) clearance from the U.S. Food and Drug Administration (FDA) to market its EksoNRTM robotic exoskeleton for use with patients with acquired brain injury (ABI). EksoNR is the first exoskeleton device to receive FDA clearance for rehabilitation use with ABI, significantly expanding the device’s indication to a broader group of patients.

The medical exoskeleton market is segmented into type, component, mobility, and application. Based on type, the market is divided into powered exoskeleton and passive exoskeleton. Based on component, the market is divided into hardware and software. Based on mobility, the market is bifurcated into stationary and mobile. Based on application, the market is divided into spinal cord injury, stroke, and others. The others segment includes multiple sclerosis, osteoarthritis, Parkinson’s disease and acquired brain injuries. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

The key players profiled in the study include CYBERDYNE INC., Ekso Bionics, Ergosanté, B-Temia, ExoAtlet, ReWalk Robotics., Ottobock SE & Co. KGaA (suit X), DIH medical Hocoma., Human Motion Technologies LLC., and Wearable Robotics srl. The players in the market have been actively engaged in the adoption various Strategies such as product launch, product approval and acquisition to remain competitive and gain advantage over the competitors in the market. For instance, in November 2022, CYBERDYNE Inc. a tech company received medical device approval for Medical HAL Single Joint Type, a Wearable CyborgTM that improves physical functions, by the Taiwan Food and Drug Administration (TFDA).

Key Market Insights

By type, the powered exoskeleton segment was the highest revenue contributor to the market and is estimated to reach $2,497.8 million by 2031, with a CAGR of 29.2%. However, the passive exoskeleton segment is estimated to be the fastest-growing segment with a CAGR of 30.0% during the forecast period.

By mobility, the stationary segment dominated the global market. However, the mobile segment is expected to be the fastest-growing segment with a CAGR of 30.3% during the forecast period.

By component, the hardware segment dominated the global market. However, the software segment is expected to be the fastest-growing segment with a CAGR of 29.9% during the forecast period.

Based on application, the spinal cord injury segment was the highest revenue contributor to the market with a CAGR of 29.9% during the forecast period.

Based on region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR of 30.6% during the forecast period

Companies Mentioned

• CYBERDYNE INC.
• Ekso Bionics
• B-Temia
• Rewalk Robotics
• Ottobock SE & Co. KGaA (suit X)
• DIH Medical
• Ergosante
• ExoAtlet
• Human Motion Technologies LLC
• Wearable Robotics srl

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

• Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
• Scientific and technical writings for product information and related preemptions
• Regional government and statistical databases for macro analysis
• Authentic news articles and other related releases for market evaluation
• Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.